# Oscar Health, Inc. (OSCR) FY2026 YTD Q2 P&L / Income Statement

- Company: Oscar Health, Inc. (OSCR)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-07, accession number 0001568651-26-000069
- Page: https://plicit.ai/financials/oscr/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/oscr-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-01-01 through 2026-06-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 9,527,414,000 US dollars
- **Total operating expenses**: 8,434,694,000 US dollars
- **Earnings (loss) from operations**: 1,092,720,000 US dollars
- **Other income (expense), net (calculated)**: negative 10,936,000 US dollars
- **Earnings (loss) before income taxes**: 1,081,784,000 US dollars
- **Income tax expense (benefit)**: 40,933,000 US dollars
- **Net income (loss)**: 1,040,851,000 US dollars
- **Premium**: 9,370,193,000 US dollars
- **Investment income**: 145,408,000 US dollars
- **Other revenues**: 11,813,000 US dollars
- **Medical**: 7,024,302,000 US dollars
- **Depreciation and amortization**: 13,078,000 US dollars
- **Selling, general, and administrative**: 1,397,314,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Oscar Health, Inc.: $1.04 B; to noncontrolling interests: $47.00 K.